Showing results (91-100 of 151) with videos related to

Sort By:
Pageof 16
Oncoscience|August 6, 2015
Durable clinical benefit to trastuzumab and chemotherapy in a patient with metastatic colon adenocarcinoma harboring ERBB2 amplificationUmut Disel, Alexis Germain, Bahar Yilmazel, et al.
Plos One|November 17, 2025
Analytical validation of a homologous recombination deficiency signature (HRDsig) in pan-tumor tissue samplesWenshu Li, Jeffrey A Leibowitz, Shuoguo Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2025
Additive Clinical Utility of Microsatellite Instability and Tumor Mutational Burden to Predict Immune Checkpoint Inhibitor Effectiveness in Metastatic Castration-Resistant Prostate CancerNicolas Sayegh, Ryon P Graf, Umang Swami, et al.
The Oncologist|September 6, 2018
Genomic Landscape of Adult and Pediatric <i>BCR-ABL1</i>-Like B-Lymphoblastic Leukemia Using Parallel DNA and RNA SequencingEric A Severson, Jo-Anne Vergilio, Laurie M Gay, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 14, 2019
SMARCA4 inactivation defines a subset of undifferentiated uterine sarcomas with rhabdoid and small cell features and germline mutation associationDouglas I Lin, Justin M Allen, Jonathan L Hecht, et al.
Cancer|December 10, 2015
Comprehensive genomic profiling of 295 cases of clinically advanced urothelial carcinoma of the urinary bladder reveals a high frequency of clinically relevant genomic alterationsJeffrey S Ross, Kai Wang, Depinder Khaira, et al.
Gynecologic Oncology|March 12, 2020
Genomic profiling of BCOR-rearranged uterine sarcomas reveals novel gene fusion partners, frequent CDK4 amplification and CDKN2A lossDouglas I Lin, Amanda Hemmerich, Claire Edgerly, et al.
The Oncologist|March 12, 2017
Clinical Benefit in Response to Palbociclib Treatment in Refractory Uterine Leiomyosarcomas with a Common <i>CDKN2A</i> AlterationJulia A Elvin, Laurie M Gay, Rita Ort, et al.
Cancer|June 6, 2017
Comprehensive genomic profiling of different subtypes of nasopharyngeal carcinoma reveals similarities and differences to guide targeted therapySiraj M Ali, Ming Yao, Jicheng Yao, et al.
Human Pathology|October 29, 2017
General paucity of genomic alteration and low tumor mutation burden in refractory and metastatic hepatoblastoma: comprehensive genomic profiling studyHwajeong Lee, Tony El Jabbour, Sanaz Ainechi, et al.
Pageof 16